 Small molecule isoindoline tetrahydroisoquinoline derivatives identified selective agonists human peroxisome proliferator-activated receptor delta (PPARdelta. Compound 18 demonstrated efficacy biomarker increased fatty acid oxidation, upregulation pyruvate dehydrogenase kinase, isozyme 4 (PDK4) human primary myotubes.